Cochlear Ltd (ASX: COH) has seen a significant decline in its share price, dropping 54.2% since the start of 2025. This prompts the question: Is it a strategic moment to consider adding COH shares to your investment watchlist? This article delves into the factors that make healthcare investments, particularly Cochlear, an attractive proposition for investors.
The Healthcare Sector's Resilience
Healthcare spending is a critical aspect of any economy, as it often represents essential services that individuals are reluctant to cut back on, even during economic downturns. This 'sticky' revenue stream is a key differentiator for healthcare companies, setting them apart from cyclical businesses that are more susceptible to fluctuations in commodity prices or seasonal demand. The Global Financial Crisis (GFC) provided a real-world example of this resilience, with healthcare emerging as the best-performing sector.
Global Healthcare Spending Growth
The healthcare sector is poised for substantial growth, particularly in the United States, which accounts for over 40% of global healthcare spending. Projections indicate that US healthcare spending will grow at an impressive rate of 7% per year from 2022 to 2027, reaching a staggering US$819 billion. This growth is not just a US phenomenon; certain sub-sectors within healthcare, such as healthcare IT, data solutions, and software-as-a-service (SaaS) companies, are expected to grow their revenue at an even more rapid pace of over 15% per year from 2024 to 2030. These growth prospects are likely to capture the interest of investors seeking substantial returns.
Ethical Investing and Sustainable Capital
The rise of ethical and sustainable investing is another factor that positions healthcare companies favorably. A Morgan Stanley survey revealed that over half of investors plan to increase their allocation to sustainable investments in 2024. With a growing emphasis on ethical practices, sectors like healthcare, which provide essential public services, are well-positioned to attract new capital and investors. This trend is likely to further boost the appeal of healthcare investments, including Cochlear.
COH Share Price Analysis
Cochlear's share price has experienced a downturn, trading below its 5-year average price-sales ratio of 9.18x. This could be interpreted as a potential opportunity for investors. However, it's essential to consider that this metric alone should not be the sole basis for investment decisions. The company's revenue has been on an upward trajectory over the last three years, indicating potential for growth. For a more comprehensive valuation, investors might consider exploring models like Discounted Cash Flow (DCF) and Dividend Discount Models (DDM), which are available through free online courses and spreadsheets offered by Rask Media.
In conclusion, the healthcare sector, exemplified by Cochlear, presents a compelling investment opportunity. Its resilience, global growth prospects, and alignment with ethical investing trends make it a sector worth watching. While the recent decline in share price may be a concern, it could also be an opportunity for investors to consider adding healthcare companies like Cochlear to their portfolios.
